Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Assets (2016 - 2025)

Firefly Neuroscience has reported Assets over the past 15 years, most recently at $10.5 million for Q4 2025.

  • Quarterly results put Assets at $10.5 million for Q4 2025, up 127.71% from a year ago — trailing twelve months through Dec 2025 was $10.5 million (up 127.71% YoY), and the annual figure for FY2025 was $10.5 million, up 127.71%.
  • Assets for Q4 2025 was $10.5 million at Firefly Neuroscience, down from $12.4 million in the prior quarter.
  • Over the last five years, Assets for AIFF hit a ceiling of $23.4 million in Q4 2021 and a floor of $2.6 million in Q4 2023.
  • Median Assets over the past 5 years was $7.6 million (2022), compared with a mean of $9.9 million.
  • Biggest five-year swings in Assets: skyrocketed 519.09% in 2021 and later plummeted 69.02% in 2023.
  • Firefly Neuroscience's Assets stood at $23.4 million in 2021, then crashed by 65.84% to $8.0 million in 2022, then plummeted by 66.91% to $2.6 million in 2023, then skyrocketed by 74.21% to $4.6 million in 2024, then skyrocketed by 127.71% to $10.5 million in 2025.
  • The last three reported values for Assets were $10.5 million (Q4 2025), $12.4 million (Q3 2025), and $14.9 million (Q2 2025) per Business Quant data.